About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Brain Imaging Technique Tracks Protein That Spreads Alzheimer’s

by Julia Samuel on January 5, 2018 at 2:56 PM
Font : A-A+

New Brain Imaging Technique Tracks Protein That Spreads Alzheimer’s

A key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread may prevent the disease from taking hold.

An estimated 44 million people worldwide are living with Alzheimer's disease, a disease whose symptoms include memory problems, changes in behavior and progressive loss of independence. These symptoms are caused by the build-up in the brain of two abnormal proteins: amyloid beta and tau. It is thought that amyloid beta occurs first, encouraging the appearance and spread of tau - and it is this latter protein that destroys the nerve cells, eating away at our memories and cognitive functions.

Advertisement


Until a few years ago, it was only possible to look at the build-up of these proteins by examining the brains of Alzheimer's patients who had died, post-mortem. However, recent developments in positron emission tomography (PET) scanning have enabled scientists to begin imaging their build-up in patients who are still alive: a patient is injected with a radioactive ligand, a tracer molecule that binds to the target (tau) and can be detected using a PET scanner.

In a study published in the journal Brain, a team led by scientists at the University of Cambridge describe using a combination of imaging techniques to examine how patterns of tau relate to the wiring of the brain in 17 patients with Alzheimer's disease, compared to controls.
Advertisement

How DOes The Brain Accumulate Tau?

Quite how tau appears throughout the brain has been the subject of speculation among scientists. One hypothesis is that harmful tau starts in one place and then spreads to other regions, setting off a chain reaction. This idea - known as 'transneuronal spread' - is supported by studies in mice.

When a mouse is injected with abnormal human tau, the protein spreads rapidly throughout the brain; however, this evidence is controversial as the amount of tau injected is much higher relative to brain size compared to levels of tau observed in human brains, and the protein spreads rapidly throughout a mouse's brain whereas it spreads slowly throughout a human brain.

There are also two other competing hypotheses. The 'metabolic vulnerability' hypothesis says that tau is made locally in nerve cells, but that some regions have higher metabolic demands and hence are more vulnerable to the protein. In these cases, tau is a marker of distress in cells.

The third hypothesis, 'trophic support', also suggests that some brain regions are more vulnerable than others, but that this is less to do with metabolic demand and more to do with a lack of nutrition to the region or with gene expression patterns.

"Five years ago, this type of study would not have been possible, but thanks to recent advances in imaging, we can test which of these hypotheses best agrees with what we observe," says Dr Thomas Cope from the Department of Clinical Neurosciences at the University of Cambridge, the study's first author.

Dr Cope and colleagues looked at the functional connections within the brains of the Alzheimer's patients - in other words, how their brains were wired up - and compared this against levels of tau. Their findings supported the idea of transneuronal spread, that tau starts in one place and spreads, but was counter to predictions from the other two hypotheses.

"If the idea of transneuronal spread is correct, then the areas of the brain that are most highly connected should have the largest build-up of tau and will pass it on to their connections. It's the same as we might see in a flu epidemic, for example - the people with the largest networks are most likely to catch flu and then to pass it on to others. And this is exactly what we saw."

Professor James Rowe, senior author on the study, adds: "In Alzheimer's disease, the most common brain region for tau to first appear is the entorhinal cortex area, which is next to the hippocampus, the 'memory region'. This is why the earliest symptoms in Alzheimer's tend to be memory problems. But our study suggests that tau then spreads across the brain, infecting and destroying nerve cells as it goes, causing the patient's symptoms to get progressively worse."

Confirmation of the transneuronal spread hypothesis is important because it suggests that we might slow down or halt the progression of Alzheimer's disease by developing drugs to stop tau from moving along neurons.

The same team also looked at 17 patients affected by another form of dementia, known as progressive supranuclear palsy (PSP), a rare condition that affects balance, vision, and speech, but not memory. In PSP patients, tau tends to be found at the base of the brain rather than throughout. The researchers found that the pattern of tau build-up in these patients supported the second two hypotheses, metabolic vulnerability, and trophic support, but not the idea that tau spreads across the brain.

The researchers also took patients at different stages of the disease and looked at how tau build-up affected the connections in their brains.

In Alzheimer's patients, they showed that as tau builds up and damages networks, the connections become more random, possibly explaining the confusion and muddled memories typical of such patients.

In PSP, the 'highways' that carry most information in healthy individuals receive the most damage, meaning that information needs to travel around the brain along a more indirect route. This may explain why, when asked a question, PSP patients may be slow to respond but will eventually arrive at the correct answer.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Parkinsons Disease Parkinsons Disease Surgical Treatment Brain Brain Facts Ataxia Magical Millets for Your Health Diet and Nutrition Tips for Athletes Nutrition IQ Language Areas in The Brain Ways to Improve your Intelligence Quotient (IQ) 

Recommended Reading
Risk Factors for Alzheimers Disease
Cognitively normal adults exhibiting atrophy of their temporal lobe or damage to blood vessels in .....
First Case of Alzheimer’s Diagnosed in a HIV-Positive Patient
Chronic HIV infection and amyloid deposition with aging may represent a "double-hit" to the brain .....
Rare Disease Could Help Find Cure for Nervous-Neurologic Disorders
Single strand breaks are one of the most common types of DNA damage and could help spot other rare ....
Diseases Related to Old Age
Ageing is referred to the accumulation of changes that brings a person closer to death....
Ataxia
Ataxia affects coordination. Gait becomes unstable and the patient loses balance. The cerebellum or ...
Diet and Nutrition Tips for Athletes
Athletes can be physically fit by consuming a well balanced nutritious diet, which keeps them mental...
Language Areas in The Brain
The mechanism of how human brain processes the language to express and comprehend the verbal, writte...
Magical Millets for Your Health
Millets are far more nutrient dense than wheat and rice. They are inexpensive and tasty too. Nutriti...
Parkinsons Disease
Parkinson’s disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. ...
Ways to Improve your Intelligence Quotient (IQ)
Intelligence quotient (IQ) is a psychological measure of human intelligence. Regular physical and me...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use